Introduction {#s1}
============

Teleosts of the medaka genus *Oryzias* were recently reported to come from different natural habitats (e.g., river, estuary, or ocean) [@pone.0055470-Roberts1], [@pone.0055470-Parenti1] and to have diverse osmoregulatory capabilities [@pone.0055470-Inoue1], [@pone.0055470-Inoue2]. Among *Oryzias* species, the brackish medaka (*Oryzias dancena*) is native to brackish water (BW) environments, such as river mouths and estuaries [@pone.0055470-Roberts1], [@pone.0055470-Parenti1], [@pone.0055470-Yusof1], and exhibits better adult survival and hatching rates of fertilized eggs in hyperosmotic environments (i.e., seawater (SW)) as compared with the Japanese medaka (*O. latipes*) [@pone.0055470-Inoue1], [@pone.0055470-Inoue2]. Along with the zebrafish (*Danio rerio*), Japanese pufferfish (*Takifugu rubripes*), and spotted green pufferfish (*Tetraodon nigroviridis*), the Japanese medaka is an important model teleost with genomic sequences available for molecular studies. However, the zebrafish is a stenohaline species, and the two pufferfish species are not easy to breed in the laboratory. In contrast, the Japanese medaka is a euryhaline freshwater (FW) teleost [@pone.0055470-Sakamoto1], [@pone.0055470-Kinoshita1] that is closely related to the brackish medaka [@pone.0055470-Inoue2], [@pone.0055470-Kinoshita1]. The brackish medaka, like the Japanese medaka, is characterized by a small size, easy breeding, short generation time, high fecundity, and transparent eggs suitable for studies of embryogenesis as well as transgenic experiments [@pone.0055470-Inoue2], [@pone.0055470-Chen1], [@pone.0055470-Sasado1]. FW fish models such as the zebrafish and Japanese medaka were established and have been widely studied in the post-genomic era, but a suitable euryhaline BW/SW fish model that can be easily bred in the laboratory and has a usable genomic database and standard molecular resources is still lacking. Given that the entire genome of the Japanese medaka has been sequenced and assembled, sufficient biological information can be extrapolated to the brackish medaka [@pone.0055470-Kasahara1], [@pone.0055470-Wittbrodt1] to support its use as a model to study the effects of salinity on various *in vivo* molecular expression [@pone.0055470-Kang1]--[@pone.0055470-Kang3]. The brackish medaka may therefore represent a good teleost model for osmoregulatory studies in saltwater environments (including BW and SW), but little is known about how their osmoregulatory systems respond to salinity challenges.

The fish Na^+^-K^+^-ATPase (NKA) is a primary driving force for the many ion transport systems activated during a salinity challenge in osmoregulatory organs such as the gills [@pone.0055470-Hirose1], [@pone.0055470-Hwang1]. NKA is a P-type ATPase consisting of an (αβ)~2~ protein complex (the catalytic α-subunit and the smaller glycosylated β-subunit) [@pone.0055470-ScheinerBobis1], [@pone.0055470-Toyoshima1]. In humans, NKA enzymatic activity is generated and maintained by ATP hydrolysis, accounting for approximately 30% of the total energy consumption [@pone.0055470-Cornelius1], [@pone.0055470-Aperia1]. In fish, the gill is the major organ responsible for osmoregulation and ionoregulation [@pone.0055470-Hirose1], [@pone.0055470-Evans1], and most euryhaline teleosts exhibit adaptive alterations in branchial NKA activity following salinity changes [@pone.0055470-Hwang1], [@pone.0055470-Evans1], [@pone.0055470-Hwang2]. In gill epithelial cells, most of the NKA detected by immunostaining is localized to mitochondrion-rich cells (MR cells; i.e., chloride cells or ionocytes) [@pone.0055470-Hirose1], [@pone.0055470-Hwang1], [@pone.0055470-Evans1]. Kang et al. [@pone.0055470-Kang1] reported that the brackish medaka and the Japanese medaka have different salinity effects on branchial NKA profiles in terms of mRNA levels, protein abundance, enzymatic activity, and the size/number of NKA-immunoreactive (IR) cells. These results indicated that the different osmoregulatory capabilities of these two closely related species may be associated with distinct adaptive responses in branchial NKA activity. It should therefore be interesting to compare modulating mechanisms of NKA responses to salinity challenges between the brackish medaka and Japanese medaka. In general, in the cells engaged in transepithelial ion transport, elevated NKA activity provides a greater driving force for ion transport, indicating an increased demand for ion uptake or secretion [@pone.0055470-Evans1], [@pone.0055470-Lin1]. NKA expression and/or activity should therefore be modulated by a variety of mechanisms under changing physiological conditions [@pone.0055470-Crambert1].

In the past decade, the FXYD (FXYD domain-containing ion transport regulator) proteins, named by their invariant FXYD motif [@pone.0055470-Sweadner1], were found to be novel regulators of NKA [@pone.0055470-Toyoshima1], [@pone.0055470-Crambert1], [@pone.0055470-Geering1]. Mammalian members of the FXYD protein family are small ubiquitous membrane proteins with a transmembrane domain and an extracellular FXYD motif that is required for the structural interaction with NKA [@pone.0055470-Toyoshima1], [@pone.0055470-Cornelius1], [@pone.0055470-Sweadner1]. The mammalian FXYD protein family consists of at least seven members, including FXYD1 (or phospholemman, PLM), FXYD2 (or the γ-subunit of NKA), FXYD3 (or mammary tumor-associated 8-kDa protein, Mat-8), FXYD4 (or corticosteroid hormone-induced factor, CHIF), FXYD5 (or related to ion channel, RIC; or dysadherin), FXYD6 (or phosphohippolin), and FXYD7 [@pone.0055470-Crambert1], [@pone.0055470-Geering1], [@pone.0055470-Garty1]. The mammalian FXYD proteins exhibit tissue-specific distribution, and all mammalian FXYD proteins are known to interact with NKA and affect its kinetic properties in specific ways [@pone.0055470-Geering1]--[@pone.0055470-Geering2]. The first reported FXYD protein in fish was a phospholemman-like protein (i.e., FXYD10) from the piked dogfish (*Squalus acanthias*) [@pone.0055470-Mahmmoud1]. Subsequent studies revealed the function of FXYD10 and its interaction with NKA [@pone.0055470-Mahmmoud2], [@pone.0055470-Mahmmoud3].

In teleosts, an interaction between a FXYD and NKA in the gills of the spotted green pufferfish was first reported by Wang et al. [@pone.0055470-Wang1]. Meanwhile, multiple FXYD proteins (e.g., FXYD2, 5--9, 11, and 12) have been reported in the zebrafish and the Atlantic salmon (*Salmo salar*) [@pone.0055470-Saito1], [@pone.0055470-Tipsmark1]. Salinity-dependent mRNA and/or protein expression of branchial FXYD members suggested their physiological significance in osmoregulatory acclimation and a role in modulating the kinetic properties of NKA [@pone.0055470-Wang1], [@pone.0055470-Tipsmark1]--[@pone.0055470-Tang1]. Although the expression and function of FXYD proteins have been widely studied in mammals and sharks, only a few studies have examined the properties of these proteins in a limited group of euryhaline teleosts. No study has yet compared the expression of FXYD proteins in related teleost species acclimated to different salinities.

We identified novel members of the FXYD family in two closely related euryhaline medaka species (brackish medaka and Japanese medaka) that show different branchial NKA responses to salinity challenge. We show that FXYD11 is a gill-specific FXYD protein and that the branchial *fxyd11* mRNA abundance was significantly higher than that of other *fxyd* genes. Our observations indicated the possibility that branchial FXYD proteins exhibited different expression patterns in the two medaka species. The present study investigated the mRNA expression patterns of *fxyd* genes in gills (the major osmoregulatory organ) of medaka acclimated to different salinity environments. By comparing the expression patterns of branchial FXYD proteins between two closely related medaka species with distinct osmoregulatory capabilities, the present study revealed different effects of salinity on teleost FXYD protein profiles. Furthermore, to study the protein levels of gill-specific FXYD11 and its interaction with NKA, we designed an antibody against the FXYD11 protein cloned from brackish medaka. To our knowledge, this report is the first to investigate FXYD expression in the gills of closely related euryhaline teleosts. The results of this study support the use of brackish medaka as a potential saltwater fish model for osmoregulatory studies.

Materials and Methods {#s2}
=====================

Ethics Statement {#s2a}
----------------

The protocol used for the experimental fish was reviewed and approved by the Institutional Animal Care and Use Committee of the National Chung Hsing University (IACUC approval no. 96-48 to THL).

Experimental animals and environments {#s2b}
-------------------------------------

Adult brackish medaka, identified by sequencing the 12S and 16S mitochondrial rRNA genes [@pone.0055470-Takehana1], were obtained from a local aquarium and were 2.6±0.2 cm in standard length. Adult reddish orange Japanese medaka (HI strain), approximately 2.5±0.3 cm standard length, were inbred in the laboratory. Brackish medaka and Japanese medaka were maintained in BW and FW, respectively. For experiments, the two medaka species were acclimated to either FW, BW, or SW for at least four weeks at 28±1°C in a 14-h light: 10-h dark cycle [@pone.0055470-Kang1]--[@pone.0055470-Kang3]. BW (15‰) and SW (35‰) were prepared from aerated dechlorinated tap FW by adding standardized amounts of the synthetic sea salt "Instant Ocean" (Aquarium Systems, Mentor, OH, USA). The details of the water parameters were identical to those used in previous studies [@pone.0055470-Kang2], [@pone.0055470-Yang1]. The water was continuously circulated through fabric-floss filters and partially refreshed every week. Dead fish were immediately removed from the experimental tanks to maintain the water quality. Fish were fed a daily diet of commercial pellets *ad libitum*. In the following experiments, fish were not fed and were anesthetized with MS-222 (100--200 mg/L) before sampling. Sampled fish were then analyzed as described below.

Total RNA extraction {#s2c}
--------------------

The methods used in this study were modified from our previous studies [@pone.0055470-Kang1]--[@pone.0055470-Kang3]. Total RNA samples from various tissues and organs of the two medaka species were extracted using RNA-Bee™ (Tel-Test, Friendwood, TX, USA) following the manufacturer\'s instructions. Genomic DNA was eliminated using the RNA clean-up protocol of the RNAspin Mini RNA isolation kit (GE Health Care, Piscataway, NJ, USA). RNA integrity was verified by 0.8% agarose gel electrophoresis. Extracted RNA samples were stored at −80°C after isolation. The concentration of the extracted RNA was measured with a NanoDrop 2000 (Thermo, Wilmington, DE, USA).

cDNA cloning of full-length *fxyd* genes {#s2d}
----------------------------------------

For RACE (rapid amplification of cDNA ends) PCR, extracted RNA samples were prepared as described above. cDNA for cloning and RACE was prepared from total RNA samples isolated from various tissues and organs (i.e., gills, kidneys, intestines, and brains) using the SuperScript III reverse transcriptase kit (Invitrogen, Carlsbad, CA, USA) and the SMART RACE cDNA amplification kit (Clontech, Palo Alto, CA, USA) following the manufacturers\' protocols. For PCR amplification, 2 µL of cDNA was used as a template in a 50 µL reaction containing 0.25 mM dNTPs, 2.5 U Hot start EX-Taq polymerase (Takara, Shiga, Japan), and 0.2 µM of each primer. Specific primer sets for RACE PCR are listed in [Table S4](#pone.0055470.s005){ref-type="supplementary-material"}. PCR products were subcloned into the pOSI-T vector (Genemark, Taipei, Taiwan), and amplicons were sequenced to confirm the PCR products.

FXYD sequences {#s2e}
--------------

To characterize the FXYD sequences, we applied the bioinformatic tools available at the National Center for Biotechnology Information (<http://www.ncbi.nlm.nih.gov/>) and the ExPASy proteomics server of the Swiss Institute of Bioinformatics (<http://www.expasy.org/sprot/>). The sequenced *fxyd* genes were deduced for open reading frames by ORF Finder (<http://www.ncbi.nlm.nih.gov/gorf/gorf.html>). Amino acid sequences for FXYD proteins from different organisms were aligned with BioEdit version 7.0.5.3 [@pone.0055470-Hall1], and a phylogenetic tree was constructed with MEGA 5 [@pone.0055470-Tamura1] using the minimum evolution method. The SignalP 4.0 server was used to predict the presence and location of signal peptide cleavage sites in the amino acid sequences (<http://www.cbs.dtu.dk/services/SignalP/>) [@pone.0055470-Petersen1]. Predictions of putative transmembrane segments were performed with the SOSUI server 1.11 (<http://bp.nuap.nagoya-u.ac.jp/sosui/>) [@pone.0055470-Hirokawa1]. Potential phosphorylation sites were predicted by the NetPhos 2.0 server (<http://www.cbs.dtu.dk/services/NetPhos/>) [@pone.0055470-Blom1]. Potential O- and N-glycosylation sites were predicted by the NetOglyc 3.1 server (<http://www.cbs.dtu.dk/services/NetOGlyc/>) [@pone.0055470-Julenius1] and NetNGlyc 1.0 server (<http://www.cbs.dtu.dk/services/NetNGlyc/>) [@pone.0055470-Johansen1], respectively.

Preparation of tissue cDNA {#s2f}
--------------------------

For reverse transcription (RT), extracted RNA samples were prepared as previously described. The first-strand cDNA was subsequently synthesized by reverse-transcribing 5 µg of total RNA using 1 µL Oligo-dT (0.5 µg/µL) primer and 1 µL PowerScript™ Reverse Transcriptase (Clontech), according to the manufacturer\'s instructions. The cDNA products were stored at −20°C until analysis by RT-PCR and quantitative real-time PCR (Q-PCR).

Analysis of *fxyd* genes in different tissues {#s2g}
---------------------------------------------

The expression of *fxyd* genes in various organs of the two medaka species was examined by RT-PCR. Primers were designed to target specific regions of the *fxyd* genes identified in the cloning results ([Table S4](#pone.0055470.s005){ref-type="supplementary-material"}). For PCR amplification (40 cycles), 1 µL of cDNA was used as a template in a 25 µL final reaction volume containing 0.25 µM dNTPs, 1.25 U Hot start EX-Taq polymerase (Takara), and 0.2 µM of each primer. The bands of PCR products were obtained by 0.8% agarose gel electrophoresis. Moreover, the PCR products were subjected to subcloned into the pOSI-T vector (Genemark) and sequenced for confirmation. Ribosomal protein L7 (RPL7/*rpl7*) was used as an internal control for all tissues ([Table S4](#pone.0055470.s005){ref-type="supplementary-material"}).

Quantitative real-time PCR (Q-PCR) {#s2h}
----------------------------------

Q-PCR was performed using a MiniOpticon real-time PCR system (Bio-Rad, Hercules, CA, USA). PCR reactions contained 8 µL of cDNA (1000× dilution), 2 µL of either 1 µM *fxyd*-QPCR primers or 1 µM *rpl7* primers (as an internal control), and 10 µL of 2× SYBR Green Supermix (Bio-Rad). The Q-PCR analysis and the formula used to calculate target gene expression were described by Kang et al. [@pone.0055470-Kang1], [@pone.0055470-Kang3]. Probe constructs for Q-PCR are shown in [Tables S4](#pone.0055470.s005){ref-type="supplementary-material"} and [S5](#pone.0055470.s006){ref-type="supplementary-material"}. The amplification efficiency of all used primer pairs was similar (ranges in 94.4--103.5% and 94.6--103.9% of the primer pairs in the brackish medaka and Japanese medaka, respectively).

Antiserum/antibody {#s2i}
------------------

The primary antisera/antibodies used in the present study included (1) FXYD11: an affinity-purified rabbit polyclonal antiserum made against a specific epitope (NQCARLVRGKRSDSSSA) corresponding to the C-terminal region of the FXYD11 protein cloned from brackish medaka (LTK BioLaboratories, Taoyuan, Taiwan), used for immunoblotting (1∶5000 dilution) and immunoprecipitation; (2) NKA: a mouse monoclonal antibody (α5, Developmental Studies Hybridoma Bank, Iowa City, IA, USA) raised against the α-subunit of the avian NKA, used for immunoblotting (1∶5000 dilution), immunohistochemical (IHC) staining (1∶400 dilution), and immunoprecipitation; and (3) RPL7: a rabbit polyclonal antibody (ab72550, Abcam, Cambridge, UK) raised against the human RPL, applied as a loading control for immunoblotting (1∶10000 dilution). The secondary antibodies used for immunoblots were horseradish peroxidase (HRP)-conjugated goat anti-mouse IgG or goat anti-rabbit IgG (\#0031430 or \#0031460, respectively; Pierce, Rockford, IL, USA).

Preparation of tissue homogenates for immunoblotting and immunoprecipitation {#s2j}
----------------------------------------------------------------------------

The methods used in this study to prepare tissue homogenates were modified from our previous studies [@pone.0055470-Kang3], [@pone.0055470-Yang2]. Various tissues and organs of the two medaka species, including gills, kidneys, and intestines, were dissected and stored immediately in a microcentrifuge tube at −80°C. Sample scrapings were suspended in a mixture of homogenization medium (SEID buffer; 150 mM sucrose, 10 mM EDTA, 50 mM imidazole and 0.1% sodium deoxycholate, pH 7.5) containing proteinase inhibitor (\#11836145001, Roche, Indianapolis, IN, USA)(v/v: 25/1). Homogenization was performed in 2 mL microtubes with a Polytron PT1200E (Kinematica, Lucerne, Switzerland) at maximal speed for 30 sec on ice. The homogenate was then centrifuged at 5,000×*g* at 4°C for 5 min. The sample supernatants were collected and used to measure protein concentrations for immunoblotting or immunoprecipitation. Protein concentrations were determined with the BCA Protein Assay (Pierce) using bovine serum albumin (BSA; Pierce) as a standard. Supernatants were stored at −80°C prior to use.

Immunoblotting {#s2k}
--------------

The immunoblotting protocol used herein was modified from our previous studies [@pone.0055470-Wang1], [@pone.0055470-Yang1], [@pone.0055470-Yang2]. For immunoblotting of branchial FXYD11, aliquots containing 40 µg of branchial supernatants were added to sample buffer and heated at 60°C for 15 min followed by electrophoresis on a 15% sodium dodecyl sulfate-polyacrylamide gel. The pre-stained protein molecular weight marker was purchased from Invitrogen (LC5925, Carlsbad, CA, USA). Separated proteins were transferred from unstained gels to PVDF membranes (Millipore, Bedford, MA, USA) by electroblotting using a tank transfer system (Mini Protean 3, Bio-Rad). Blots were preincubated for 2 h in PBST (phosphate buffer saline with 0.05% Tween-20) buffer containing 5% (wt/vol) nonfat dried milk to minimize non-specific binding. The blots were then incubated with the primary antibody (FXYD11) diluted in 1% BSA and 0.05% sodium azide in PBST and subsequently with the HRP-conjugated secondary antibody diluted in PBST. The blots were developed using the SuperSignal West Pico Detection Kit (\#34082, Pierce) and observed in a Universal hood with a cooling-CCD (charge-coupled device) camera (ChemiDoc XRS+, Bio-Rad) and the associated software (Quantity One version 4.6.8, Bio-Rad). Immunoreactive bands were analyzed using Image Lab software version 3.0 (Bio-Rad). The results were converted to numerical values to compare the relative protein abundances of the immunoreactive bands.

To confirm that the immunoreactivity was due to the presence of FXYD11 rather than non-specific binding, various tissue/organ supernatants were subjected to immunoblotting ([Figure S1](#pone.0055470.s001){ref-type="supplementary-material"}). Meanwhile, rabbit pre-immune serum was substituted for the primary antiserum in the negative control. The immunoblotting protocol was identical to that described above.

Co-immunoprecipitation (Co-IP) {#s2l}
------------------------------

Gill total lysates were used in this experiment. IP with the FXYD11 antibody, the NKA antibody (α5; positive control), or pre-serum (negative control) was carried out with the ImmunoCruz™ IP/WB Optima System (sc-45042 or sc-45043, Santa Cruz Biotechnology, Santa Cruz, CA, USA) according to the manufacturer\'s manual. After elution, the samples were stored at 4°C prior to use. To confirm the interaction between FXYD11 and the NKA α-subunit, the above IP solutions were subjected to NKA immunoblotting and analyzed by electrophoresis on a 7% sodium dodecyl sulfate-polyacrylamide gel as described above.

Whole-mount *in situ* hybridization (WISH) of *fxyd11* in gills {#s2m}
---------------------------------------------------------------

The WISH protocol was modified from Kang et al. [@pone.0055470-Kang2]. A cDNA fragment corresponding to *fxyd11* (692 bp) of brackish medaka was amplified with Probe-F and R primers ([Table S4](#pone.0055470.s005){ref-type="supplementary-material"}) by PCR and inserted into the pOSI-T vector (Genemark). After amplifying the target gene by PCR with T7 and SP6 primers, products were subjected to *in vitro* transcription with T7 and SP6 RNA polymerases (Takara), respectively. Dig-labeled RNA probes were examined by RNA gel electrophoresis to confirm their quality and concentration. Four pairs of gills from FW-acclimated brackish medaka were excised and fixed in 4% paraformaldehyde (PFA) in a diethyl pyrocarbonate (DEPC)-PBS solution (1.4 mM NaCl, 0.2 mM KCl, 0.1 mM Na~2~HPO~4~, and 0.002 mM KH~2~PO~4~) at 4°C for 2 h and then washed with DEPC-PBS. The gills were treated with methanol at −20°C overnight and washed with DEPC-PBST (PBS with 0.1% Tween-20) twice for 10 min each. Samples were prehybridized with hybridization buffer (HyB; 60% formamide, 5× SSC (saline-sodium citrate buffer), 0.1% Tween-20, 500 µg/mL yeast tRNA and 50 µg/mL heparin) for 2 h at 65°C and then hybridized with probe (20 ng) in HyB overnight at 67°C. The next day, samples were washed in a series of HyB/SSC solutions at 67°C and then in a series of SSC/PBST buffers at room temperature. Samples were blocked with 5% sheep serum in 2 mg/mL BSA (Sigma-Aldrich, St. Louis, MO, USA) at room temperature for 2 h and then incubated with an anti-Dig Fab (1∶5000 in blocking solution) at 4°C overnight. After washing with DEPC-PBST at room temperature 8 times for 15 min each, gills were exposed to staining buffer (0.1 M Tris pH 9.5, 50 mM MgCl~2~, 0.1 M NaCl and 0.1% Tween-20) twice for 10 min and then developed by incubating with the NBT/BCIP kit (Zymed, South San Francisco, CA, USA) for 1.5 h in the dark. The reaction was stopped by PFA, and the samples were subsequently washed twice with methanol. Samples were stored in DEPC-PBST at 4°C in the dark until further examination and analysis.

Cryosectioning and immunohistochemical staining {#s2n}
-----------------------------------------------

The IHC methods used in this study were modified from previous studies [@pone.0055470-Kang2], [@pone.0055470-Kang3], [@pone.0055470-Yang1]. Gills subjected to *in situ* hybridization were fixed with 10% neutral buffered formalin, infiltrated with OCT (optimal cutting temperature) compound (Sakura, Tissue-Tek, Torrance, CA, USA) overnight at 4°C and then mounted for cryosectioning. The tissue was cryosectioned (5 µm) using a Cryostat Microtome (CM3050S, Leica, Wetzlar, Germany) at −25°C. Sections were placed on 0.01% poly-L-lysine-coated slides (Sigma) and kept in slide boxes at −20°C. Cryosections of *in situ* hybridized gills were washed with PBS and then observed under an optical microscope (BX50, Olympus, Tokyo, Japan). The first micrographs were taken using the cooling-CCD camera (DP72, Olympus) with the associated software (CellSens standard version 1.4, Olympus). Sections were then stained with a monoclonal antibody (α5) to label the NKA α-subunit, followed by a commercial kit (PicTure™; Zymed) for visualizing the immunoreaction. After staining, sections were mounted in Clearmount™ (Zymed), cover-slipped, and the second micrographs were taken in the same region of the same gill filament. Comparing the first and second micrographs of the same region of the gill filament revealed the colocalization of the *in situ* reaction and NKA-immunoreactive (NKA-IR) cells in the gill filaments.

Statistical analysis {#s2o}
--------------------

Values are expressed as means ± SEM (standard error of the mean). Results were compared by one-way ANOVA with Tukey\'s pairwise method using SPSS 12.0 software (SPSS, Inc., Chicago, IL, USA), and *P*\<0.05 was set as the significance level.

Results {#s3}
=======

Sequence characteristics and phylogenetic analysis of medaka FXYD proteins {#s3a}
--------------------------------------------------------------------------

Fourteen members of the FXYD protein family were cloned from brackish medaka (OdFXYD) and Japanese medaka (OlFXYD)([Figure 1](#pone-0055470-g001){ref-type="fig"}; accession numbers are listed in [Table S1](#pone.0055470.s002){ref-type="supplementary-material"}). All fourteen were small proteins, comprising approximately 65--176 amino acid residues ([Table S2](#pone.0055470.s003){ref-type="supplementary-material"}). An alignment revealed that these FXYD proteins contain the highly similar FXYD motif followed by a tyrosine and a number of conserved residues in the transmembrane domain (red and blue text in [Figure 1](#pone-0055470-g001){ref-type="fig"}, respectively). The deduced protein sequences were examined for the potential presence of signal peptides, membrane domains, phosphorylation sites, and glycosylation sites (details are provided in [Table S2](#pone.0055470.s003){ref-type="supplementary-material"}). A hydropathy analysis determined that all of the medaka FXYD proteins contain one transmembrane domain (green underlined text in [Figure 1](#pone-0055470-g001){ref-type="fig"}), while most also contain a signal peptide (gray background) and phosphorylation sites (pink text)([Figure 1](#pone-0055470-g001){ref-type="fig"}; [Table S2](#pone.0055470.s003){ref-type="supplementary-material"}). Forty-eight FXYD proteins from ten vertebrate species, including fish and mammals, were then aligned and compared ([Figure 2](#pone-0055470-g002){ref-type="fig"}; accession numbers are listed in [Table S3](#pone.0055470.s004){ref-type="supplementary-material"}). The teleostean FXYD11 and 12 proteins were isolated from other members of the FXYD protein family in the phylogenetic tree. Across all FXYD family members, the FXYD proteins of the two medaka species were very closely related and clearly grouped in the same clade. Moreover, higher identities were found between the homologous FXYD proteins of the two medaka species as compared with the other FXYD homologues from teleosts and mammals ([Table 1](#pone-0055470-t001){ref-type="table"}). Among the different FXYD members, teleost FXYD9 proteins showed the highest identity (90.0--97.5%).

![Alignment of putative amino acid sequences of the FXYD proteins in the brackish medaka (Od, A) and Japanese medaka (Ol, B).\
Red text indicates the FXYD motif; the conserved residues in the conserved region (from the FXYD motif to the end of the transmembrane domain) are shown in blue; the predicted signal peptides are shown with a gray background; the predicted transmembrane domains are shown in green underlined text; and the predicted sites for phosphorylation are shown in pink text.](pone.0055470.g001){#pone-0055470-g001}

![Phylogenetic tree of FXYD proteins using the minimum evolution method.\
The tree was generated using FXYD protein sequences from different species, including human (Hs, *Homo sapiens*), mouse (Mm, *Mus musculus*), spiny dogfish (Sa, *Squalus acanthias*), zebrafish (Dr, *Danio rerio*), Atlantic salmon (Ss, *Salmo salar*), European eel (Aa, *Anguilla anguilla*), Japanese eel (Aj, *Anguilla japonica*), brackish medaka (Od, *Oryzias dancena*), and Japanese medaka (Ol, *O. latipes*). Numbers represent bootstrap values for the percentage of 1000 replicates. Accession numbers are listed in [Tables S1](#pone.0055470.s002){ref-type="supplementary-material"} and [S3](#pone.0055470.s004){ref-type="supplementary-material"}.](pone.0055470.g002){#pone-0055470-g002}
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###### Amino acid identity (%) of FXYD proteins of the brackish medaka and Japanese medaka as compared with other homologues from teleosts and mammals.

![](pone.0055470.t001){#pone-0055470-t001-1}

  Medaka                  Teleosts   Mammals                       
  ---------------------- ---------- --------- ------ ------ ------ ------
  Brackish medaka (Od)                                             
  OdFXYD5                   87.5      60.0     55.0   ---    42.5   35.0
  OdFXYD6                   90.0      82.5     65.0   87.5   72.5   72.5
  OdFXYD7                   85.0      72.5     70.0   87.5   47.5   52.5
  OdFXYD8                   90.0      67.5     70.0   72.5   ---    ---
  OdFXYD9                   97.5      95.0     92.5   97.5   ---    ---
  OdFXYD11                  80.0      55.0     50.0   50.0   ---    ---
  OdFXYD12                  87.5      82.5     62.5   80.0   ---    ---
  Japanese medaka (Ol)                                             
  OlFXYD5                   ---       60.0     57.5   ---    47.5   37.5
  OlFXYD6                   ---       80.0     60.0   90.0   72.5   72.5
  OlFXYD7                   ---       70.0     70.0   80.0   45.0   47.5
  OlFXYD8                   ---       75.0     75.0   77.5   ---    ---
  OlFXYD9                   ---       92.5     90.0   95.0   ---    ---
  OlFXYD11                  ---       60.0     60.0   52.5   ---    ---
  OlFXYD12                  ---       80.0     62.5   80.0   ---    ---

Homologies were evaluated for the 40 amino acids of the conserved region (from 3 amino acids before the FXYD motif to the rear of the transmembrane domain). Accession numbers are listed in [Tables S1](#pone.0055470.s002){ref-type="supplementary-material"} and [S3](#pone.0055470.s004){ref-type="supplementary-material"}. Dr, zebrafish; Ss, Atlantic salmon; On, Nile tilapia; Hs, human; Mm, mouse; ---, not applicable.

Tissue distribution of *fxyd* genes {#s3b}
-----------------------------------

An RT-PCR analysis followed by electrophoresis characterized the tissue-specific expression pattern of *fxyd* genes in the BW-acclimated brackish medaka and FW-acclimated Japanese medaka ([Figure 3](#pone-0055470-g003){ref-type="fig"}). The *rpl7* gene was used as an internal control to confirm cDNA quality. Expression profiles of the 14 *fxyd* genes were analyzed in the osmoregulatory organs (gill, kidney, and intestine) as well as other organs/tissues. Similar patterns were observed in the brackish medaka and Japanese medaka. Most of the *fxyd* genes were expressed in the osmoregulatory organs, among which three *fxyd* genes (*fxyd5*, *8*, and *9*) were broadly distributed in a number of different organs/tissues, and *fxyd11* was expressed most prominently in the gill.

![Tissue distribution of *fxyd* genes as detected by RT-PCR in the brackish water-acclimated brackish medaka (Od, A) and freshwater-acclimated Japanese medaka (Ol, B).\
The *rpl7* gene was used as an internal control. G, gill; I, intestine; K, kidney; B, brain; E, eye; L, liver; CF, caudal fin.](pone.0055470.g003){#pone-0055470-g003}

Branchial *fxyd* mRNA levels {#s3c}
----------------------------

The expression profiles of branchial *fxyd* genes were similar between the brackish medaka and Japanese medaka ([Figure 4](#pone-0055470-g004){ref-type="fig"}). In the gill, *fxyd11* and *fxyd9* mRNA levels were the highest and second highest, respectively, among all detected *fxyd* genes in both medaka species. The gill mRNA levels of *fxyd11* were approximately 19- and 7-fold higher than that of *fxyd9* in brackish medaka and Japanese medaka, respectively. Conversely, the mRNA levels of *fxyd6*, *7*, and *12* were low in the gills of both medaka species.

![Comparisons of branchial *fxyd* mRNA abundance in the brackish medaka (Od, A) and the Japanese medaka (Ol, B).\
Values are means ± SEM (N = 10). Different letters indicate significant differences among *fxyd* genes, excluding *fxyd11* (one-way ANOVA with Tukey\'s comparison, *P*\<0.05).](pone.0055470.g004){#pone-0055470-g004}

Salinity effects on the expression of branchial *fxyd* genes {#s3d}
------------------------------------------------------------

The expression of most *fxyd* genes in the gills of brackish medaka and Japanese medaka was salinity-dependent ([Figures 5](#pone-0055470-g005){ref-type="fig"} and [6](#pone-0055470-g006){ref-type="fig"}). Gill *Odfxyd11* mRNA levels were significantly higher in FW-acclimated brackish medaka than in BW- or SW-acclimated fish (approximately 5.7-fold; [Figure 5A](#pone-0055470-g005){ref-type="fig"}; [Table 2](#pone-0055470-t002){ref-type="table"}). In the Japanese medaka, however, the highest relative mRNA abundance of branchial *Olfxyd11* was found in the SW-acclimated individuals ([Figure 5B](#pone-0055470-g005){ref-type="fig"}). [Figure 6](#pone-0055470-g006){ref-type="fig"} shows the expression levels of other *fxyd* genes in medaka acclimated to FW, BW, and SW. The expression pattern of *Odfxyd12* was similar to that of *Odfxyd11* in the gills of the brackish medaka ([Figure 6F](#pone-0055470-g006){ref-type="fig"}). The highest levels of branchial *Odfxyd5*, *6*, and *8*, however, were found in the gills of BW-acclimated brackish medaka ([Figure 6A, B, D](#pone-0055470-g006){ref-type="fig"}). No significant difference in branchial *Odfxyd7* and *9* expression was found among the salinity groups ([Figure 6C and E](#pone-0055470-g006){ref-type="fig"}). In contrast, the mRNA levels of *Olfxyd5*, *8*, and *12* were significantly higher in gills of SW-acclimated Japanese medaka than in the other salinity groups ([Figure 6G, J, and L](#pone-0055470-g006){ref-type="fig"}). Similar to the branchial *fxyd* patterns of the brackish medaka, the highest level of *Olfxyd6* was found in the gills of BW-acclimated Japanese medaka ([Figure 6H](#pone-0055470-g006){ref-type="fig"}), and the expression of *Olfxyd7* and *9* was not salinity-dependent ([Figure 6I and K](#pone-0055470-g006){ref-type="fig"}).

![Salinity effects on branchial *fxyd11* mRNA abundance in the brackish medaka (Od, A) and the Japanese medaka (Ol, B).\
Values are means ± SEM (N = 6). Different letters indicate significant differences among salinity groups (one-way ANOVA with Tukey\'s comparison, *P*\<0.05). FW, fresh water; BW, brackish water; SW, seawater.](pone.0055470.g005){#pone-0055470-g005}

![Salinity effects on multiple *fxyd* mRNA abundance in gills of the brackish medaka (Od, A--F) and Japanese medaka (Ol, G--L).\
Values are means ± SEM (N = 4). Different letters indicate significant differences among salinity groups (one-way ANOVA with Tukey\'s comparison, *P*\<0.05). FW, fresh water; BW, brackish water; SW, seawater.](pone.0055470.g006){#pone-0055470-g006}

10.1371/journal.pone.0055470.t002

###### Salinity effects on FXYD11 and NKA expression patterns in gills of the brackish medaka (Od) and Japanese medaka (Ol).

![](pone.0055470.t002){#pone-0055470-t002-2}

  Medaka         Protein        Expression ratios (FW ∶ BW ∶ SW)
  -------- ------------------- ----------------------------------
  Od           mRNA levels     
                 FXYD11             5.7^a^ ∶ 1.0^b^ ∶ 2.0^c^
              NKA α-subunit         3.7^a^ ∶ 1.0^b^ ∶ 1.3^b^
            Protein abundance  
                 FXYD11             2.0^a^ ∶ 1.0^b^ ∶ 1.3^b^
              NKA α-subunit         1.6^a^ ∶ 1.0^b^ ∶ 1.7^a^
                Activity       
                   NKA              4.5^a^ ∶ 1.0^b^ ∶ 3.7^a^
  Ol           mRNA levels     
                 FXYD11             1.0^a^ ∶ 0.6^b^ ∶ 1.5^c^
              NKA α-subunit         1.0^a^ ∶ 0.8^a^ ∶ 1.6^b^
            Protein abundance  
                 FXYD11                       ---
              NKA α-subunit         1.0^a^ ∶ 2.3^b^ ∶ 2.5^b^
                Activity       
                   NKA              1.0^a^ ∶ 1.4^a^ ∶ 3.9^b^

The ratios were calculated based on the expression of the brackish water-acclimated brackish medaka or freshwater-acclimated Japanese medaka. The NKA expression data were modified from Kang et al. [@pone.0055470-Kang1]. Different letters indicate significant differences among salinity groups (one-way ANOVA with Tukey\'s comparison, *P*\<0.05). FW, fresh water; BW, brackish water; SW, seawater; ---, not determined.

Expression patterns of gill-specific FXYD11 in the brackish medaka {#s3e}
------------------------------------------------------------------

Quantification of the immunoreactive bands in protein samples from different salinity groups revealed that FW-acclimated brackish medaka had the highest abundance of branchial OdFXYD11, 2.0-fold higher than the levels detected in the other groups ([Figure 7](#pone-0055470-g007){ref-type="fig"}; [Table 2](#pone-0055470-t002){ref-type="table"}). The interaction between OdFXYD11 and OdNKA was then examined by co-immunoprecipitation (Co-IP; [Figure 8](#pone-0055470-g008){ref-type="fig"}). When FXYD11 was precipitated, a immunoreactive band was detected at 100 kDa (F11, lane 1 of [Figure 8](#pone-0055470-g008){ref-type="fig"}), corresponding to the molecular mass of the NKA α-subunit protein. No Co-IP immunoreaction was observed following the use of pre-immune serum (Pre, lane 2 of [Figure 8](#pone-0055470-g008){ref-type="fig"}). Lane 3 (α5; IP with the NKA antibody) and lane 4 (G; gill total lysates without IP) are positive controls demonstrating the immunoprecipitation efficiency. These data indicate that OdFXYD11 possibly interacts with NKA in the gills of the brackish medaka.

![Salinity effects on branchial OdFXYD11 protein abundance in the brackish medaka.\
Representative immunoblots (A) and relative intensities (B) of OdFXYD11 and OdRPL7 (internal control) expression in the various groups. Values are means ± SEM (N = 5). Different letters indicate significant differences among salinity groups (one-way ANOVA with Tukey\'s comparison, *P*\<0.05). FW, fresh water; BW, brackish water; SW, seawater; a.u., arbitrary units.](pone.0055470.g007){#pone-0055470-g007}

![Co-immunoprecipitation of OdNKA with OdFXYD11 in freshwater-acclimated brackish medaka.\
FXYD11 was immunoprecipitated from gill total lysates with a primary antibody, and then the immune complexes were analyzed by SDS-PAGE and immunoblotted for the NKA protein. Immunoreactive bands for NKA were detected at 100 kDa. F11, western blot detection of the FXYD11 antibody (experimental group); Pre, negative immunoblot control using pre-immune serum for the immunoprecipitation; α5, positive immunoblot control using the same antibody (NKA, α5) for the immunoprecipitation; G, positive immunoblot control using gill total lysates without the immunoprecipitation.](pone.0055470.g008){#pone-0055470-g008}

To determine the localization pattern of *Odfxyd11*, an anti-sense RNA probe was used to detect *Odfxyd11* in gills of the FW-acclimated brackish medaka ([Figure 9](#pone-0055470-g009){ref-type="fig"}). Positive signals (purple) were mainly confined to the epithelial cells of the afferent region of the gill filament ([Figure 9B and C](#pone-0055470-g009){ref-type="fig"}). The sense probe revealed no signal in the same region ([Figure 9A](#pone-0055470-g009){ref-type="fig"}). Gill cryosections were then counterstained with the NKA α-subunit antibody (α5), which revealed that the *Odfxyd11*-expressing epithelial cells also showed immunoreactivity for NKA ([Figure 9D](#pone-0055470-g009){ref-type="fig"}). Taken together, these results demonstrate that *Odfxyd11* expression is localized to the NKA-IR cells in the gill epithelia of the brackish medaka and that OdFXYD11 possibly interacts with the NKA α-subunit upon salinity challenge.

![Localization of *Odfxyd11* mRNA in gill sections of freshwater-acclimated brackish medaka.\
Cryosections of gill filaments labeled with sense probe (A; control) or anti-sense probe (B) show counterstaining with *Odfxyd11* probes. (C) Positive *Odfxyd11* signals (purple) were localized to epithelial cells of the gill filament. (D) The NKA immunoreactive cells (dark red) are identical to the epithelial cells labeled with the *Odfxyd11* probe in the same cryosection. AF, afferent region; C, cartilage; EF, efferent region; L, lamellae. Scale bar = 20 µm.](pone.0055470.g009){#pone-0055470-g009}

Discussion {#s4}
==========

In teleosts, branchial NKA proteins play a crucial role in osmoregulatory organs in driving the action of other transporters and channels to regulate ion concentrations and maintain a stable internal environment [@pone.0055470-Hwang1], [@pone.0055470-Evans1]. It has recently become clear that mammalian FXYD proteins modulate NKA activity [@pone.0055470-Crambert1], [@pone.0055470-Geering1]--[@pone.0055470-Geering2]. To date, few studies have investigated the salinity-dependent expression of FXYD proteins in teleosts, and these studies have focused on a rather limited group of species, including the euryhaline pufferfish [@pone.0055470-Wang1] and tilapia [@pone.0055470-Tipsmark3], the anadromous salmon [@pone.0055470-Tipsmark1]--[@pone.0055470-Bystriansky1], the catadromous eel [@pone.0055470-Tang1], and the stenohaline zebrafish [@pone.0055470-Saito1]. In this study, we revealed similar and different expression of branchial *fxyd* genes in two closely related medaka species. The results will shed more light on the relationship between FXYD proteins and NKA of euryhaline teleosts. The present study identified novel members of the teleostean FXYD protein family and examined their tissue distributions and responses to changes in environmental salinity. We also investigated the effects of salinity on the protein abundance of gill-specific FXYD11 in the brackish medaka. Our results indicate that the brackish medaka is an appropriate and useful saltwater (including BW and SW) fish model for osmoregulatory studies.

Fourteen members of FXYD protein family (FXYD5--9, 11, and 12) were identified in the brackish medaka and Japanese medaka ([Figures 1](#pone-0055470-g001){ref-type="fig"} and [2](#pone-0055470-g002){ref-type="fig"}). According to the deduced amino acid sequences, these medaka FXYD proteins share the characteristic features of other FXYD proteins in mammals and fish, including one transmembrane domain with an extracellular N-terminus, a cytoplasmic C-terminus, and a highly similar FXYD motif at the N-terminus ([Figure 1](#pone-0055470-g001){ref-type="fig"}). Moreover, the high degree of homology between the FXYD proteins of the two species ([Figure 2](#pone-0055470-g002){ref-type="fig"}; [Table 1](#pone-0055470-t001){ref-type="table"}) not only further strengthens their close phylogenetic relationship but also implies that the homologous FXYD proteins might serve similar functions [@pone.0055470-Wang1], [@pone.0055470-Tipsmark2]. To date, eight members of the FXYD protein family (FXYD2, 5--9, 11, and 12) have been reported in both the Atlantic salmon and the zebrafish [@pone.0055470-Saito1], [@pone.0055470-Tipsmark1]. Relative to mammalian FXYD proteins, FXYD9--12 are specific to fish. However, unlike the FXYD proteins of mammals and sharks, the functions of the teleost FXYD proteins are poorly understood. Mammalian and shark FXYD proteins were reported to function as modulators of NKA, with different family members exerting different effects on NKA activity [@pone.0055470-Crambert1], [@pone.0055470-Garty1], [@pone.0055470-Geering2]. For instance, FXYD1 and FXYD10 were shown to inhibit NKA activity [@pone.0055470-Mahmmoud2], [@pone.0055470-Feschenko1], whereas FXYD4 was reported to stimulate NKA activity [@pone.0055470-Garty2]. Although the functions and molecular mechanisms of teleostean FXYD proteins have not yet been clarified, additional studies aimed at understanding the effects of salinity on teleost FXYD protein expression profiles will likely illustrate the potential roles of FXYD proteins in the osmoregulatory response to salinity challenges.

Most medaka *fxyd* genes were expressed in osmoregulatory organs (i.e., gill, kidney, and intestine; [Figure 3](#pone-0055470-g003){ref-type="fig"}). Similar patterns were reported in the Atlantic salmon and the zebrafish [@pone.0055470-Saito1], [@pone.0055470-Tipsmark1]. Like the mammalian *fxyd* genes [@pone.0055470-Crambert1], [@pone.0055470-Garty1], the expression of certain *fxyd* genes was tissue-specific in both medaka species. Similar to rat *fxyd7* [@pone.0055470-Bguin1], *fxyd7* is primarily expressed in the brain of the brackish medaka, Japanese medaka ([Figure 3](#pone-0055470-g003){ref-type="fig"}), and Atlantic salmon [@pone.0055470-Tipsmark1]. However, zebrafish *fxyd7* was ubiquitously distributed [@pone.0055470-Saito1]. In contrast, medaka *fxyd5*, *8*, and *9* were broadly distributed in various organs/tissues. Similar patterns were observed for *fxyd8* in the zebrafish and for *fxyd9* in all reported teleosts [@pone.0055470-Wang1]--[@pone.0055470-Tipsmark1], [@pone.0055470-Tipsmark3]. Conversely, in the Atlantic salmon, *fxyd5* is predominantly expressed in the kidney and heart [@pone.0055470-Tipsmark1]. Although the tissue distributions of teleost *fxyd* genes thus vary across species, the patterns were very similar between the brackish medaka and Japanese medaka. For example, *fxyd11* was highly enriched in the gills of both medaka species ([Figures 3](#pone-0055470-g003){ref-type="fig"} and [\[4\]](#pone-0055470-g004){ref-type="fig"}) as well as the other studied teleosts, with the exception of the spotted green pufferfish [@pone.0055470-Wang1]--[@pone.0055470-Tipsmark1],[@pone.0055470-Tipsmark3],[@pone.0055470-Tang1]. FXYD11 interacts with the NKA α-subunit in branchial NKA-IR cells of the brackish medaka ([Figures 8](#pone-0055470-g008){ref-type="fig"} and [\[9\]](#pone-0055470-g009){ref-type="fig"}), the zebrafish [@pone.0055470-Saito1], and the Atlantic salmon [@pone.0055470-Tipsmark2]. These interactions have been established through different approaches, including Co-IP, *in situ* hybridization, *in situ* proximity ligation assay, and immunostaining.

Among all detected *fxyd* genes, *fxyd11* was the most highly expressed in the gills of the brackish medaka, Japanese medaka ([Figure 4](#pone-0055470-g004){ref-type="fig"}), and Atlantic salmon [@pone.0055470-Tipsmark1]. In addition, higher levels (mRNA/protein) of branchial FXYD11 were found in SW-acclimated Atlantic salmon and Japanese eel (*Anguilla japonica*) as well as in ion-poor water-acclimated zebrafish relative to FW-acclimated individuals [@pone.0055470-Saito1], [@pone.0055470-Tipsmark2], [@pone.0055470-Tang1]. These studies also showed that the expression of FXYD11 and the NKA α-subunit increased in parallel [@pone.0055470-Hwang1], indicating that teleostean FXYD11 might enhance NKA activity in the gills [@pone.0055470-Saito1], [@pone.0055470-Tipsmark2].

Salinity-dependent expression of branchial *fxyd11* was also observed in the brackish medaka and Japanese medaka ([Figure 5](#pone-0055470-g005){ref-type="fig"}). Different from the comparisons made between FW and SW groups in the other studied teleosts, we acclimated individuals from the two medaka species to FW, BW, or SW for subsequent investigations. The expression patterns (U-shape) of branchial *fxyd11* were similar between the two species, but the highest expression was found in different salinity groups ([Figure 5](#pone-0055470-g005){ref-type="fig"}). Similar to the other studied teleosts, in the Japanese medaka, *Olfxyd11* was more highly expressed in SW-acclimated individuals than in FW-acclimated fish [@pone.0055470-Tipsmark2], [@pone.0055470-Tang1]. Conversely, higher branchial *Odfxyd11* expression was detected in FW-acclimated brackish medaka. When the branchial mRNA levels of *Olfxyd11* were compared to those of the *nka* α-subunit in the Japanese medaka, parallel increases in expression were noted ([Table 2](#pone-0055470-t002){ref-type="table"}), similar to other teleosts [@pone.0055470-Tipsmark2], [@pone.0055470-Tang1]. In the gills of the brackish medaka, however, the OdFXYD11 expression patterns (both mRNA and protein abundance) differed from those of the NKA α-subunit ([Table 2](#pone-0055470-t002){ref-type="table"}), such that the expression of branchial OdFXYD11 did not change with NKA expression. Possible reasons may be more than one, such as the composition of NKA α-subunits isoforms or other functions of FXYD11. Although further mechanism is yet unknown, this is the first case of uncorrelated FXYD11/NKA expression to be reported in the teleost. Furthermore, previous time-course experiments revealed that the mRNA abundance of branchial *fxyd11* was not correlated with branchial NKA expression (either mRNA or activity) in the Atlantic salmon and the Mozambique tilapia [@pone.0055470-Tipsmark2]--[@pone.0055470-Tipsmark3]. On the other hand, mRNA and protein expression of branchial FXYD11 was found to be influenced by hormones [@pone.0055470-Tipsmark2], [@pone.0055470-Tipsmark3], [@pone.0055470-Tang1]. These results indicate that FXYD11 modulates NKA activity in multiple ways rather than simply increasing expression in parallel with NKA. In mammals, FXYD proteins affect NKA responses (e.g., composition, apparent ion affinities, and maximal pump current) via differential phosphorylation, hormones, and interactive levels [@pone.0055470-Toyoshima1], [@pone.0055470-Garty1], [@pone.0055470-Li1]. Taken together, these observations on the distribution and expression of FXYD11 in the two medaka species indicate that FXYD11 is a unique member of the FXYD protein family specific to the gill and that branchial FXYD11 may play a crucial role in osmoregulation via modulating NKA expression [@pone.0055470-Saito1], [@pone.0055470-Tipsmark1], [@pone.0055470-Tang1]. Our results also suggest that FXYD11 might use diverse modulatory mechanisms in response to salinity challenges in the gills of the two medaka species.

In the gills of both the brackish medaka and Japanese medaka, *fxyd9* was the second most highly expressed *fxyd* gene, but its expression was not salinity-dependent ([Figures 4](#pone-0055470-g004){ref-type="fig"} and [6](#pone-0055470-g006){ref-type="fig"}). This pattern is different from that of the spotted green pufferfish, where higher levels (mRNA and protein) of branchial FXYD9 were found in FW-acclimated individuals as compared with SW-acclimated fish [@pone.0055470-Wang1]. In time-course experiments performed with the Atlantic salmon, however, the expression of branchial *fxyd9* showed no differences between time-points after the fish were transferred from FW to SW and *vice versa* [@pone.0055470-Tipsmark2], [@pone.0055470-Bystriansky1]. In the gills of the Mozambique tilapia, *fxyd9* levels increased when the fish were transferred from SW to FW and rose quickly and then recovered gradually upon transfer from FW to SW [@pone.0055470-Tipsmark3]. Although the expression patterns of branchial *fxyd9* differ among these teleosts, the higher levels of branchial FXYD9 in the spotted green pufferfish and Mozambique tilapia were found in environments of low NKA activity [@pone.0055470-Wang1], [@pone.0055470-Tipsmark3]. In the spotted green pufferfish, branchial FXYD9 was inferred to inhibit NKA activity because of its high similarity to human FXYD3 and shark FXYD10 as well as the opposite expression pattern of NKA after salinity challenges [@pone.0055470-Wang1]. In this study, the constant and broadly distributed expression of *fxyd9* suggests that it may function as a housekeeping gene and play a role in co-modulating NKA expression with FXYD11 in the gills of the two medaka species. The expression levels of the other branchial *fxyd* genes were much lower, especially *fxyd6*, *7*, and *12*, relative to *fxyd11* and *9* ([Figure 4](#pone-0055470-g004){ref-type="fig"}). Although the gill expression of several *fxyd* genes (i.e., *fxyd5*, *6*, *8*, and *12*) was salinity-dependent in both species ([Figure 6](#pone-0055470-g006){ref-type="fig"}), the functions of these genes require further elucidation.

In this study, we investigated changes in the expression of the *fxyd* genes in two closely related medaka species upon salinity challenges. Our comparison of *fxyd* genes expression patterns between two medaka species with diverse osmoregulatory capabilities revealed both similar (e.g., tissue distributions) and different (e.g., *fxyd11* expression) patterns. Moreover, a different pattern was found that the branchial OdFXYD11 expression was the highest in the FW-acclimated individuals, unlike those reported in the other teleosts including the Japanese medaka ([Figure 5](#pone-0055470-g005){ref-type="fig"}) [@pone.0055470-Tipsmark2], [@pone.0055470-Tang1]. These results indicate that the species\' responses (e.g., FXYD and NKA expression and salinity tolerance) to salinity changes might be related to their evolutionary histories, natural habitats, and/or developmental stages [@pone.0055470-Hwang2], [@pone.0055470-Freire1], [@pone.0055470-Cutler1]. Thus, the choice of an appropriate animal model is important for osmoregulatory studies involving salinity challenges. Based on their close phylogenetic relationships and diverse characteristics, *Oryzias* species offer unique models for comparative and osmoregulatory studies [@pone.0055470-Inoue1], [@pone.0055470-Inoue2], [@pone.0055470-Inoue3]. The brackish medaka represents a unique model because it shows better salinity tolerance and hyposmoregulatory ability than the Japanese medaka [@pone.0055470-Inoue1], [@pone.0055470-Inoue2],[@pone.0055470-Kang1]. Moreover, the entire genome of the Japanese medaka has been sequenced and annotated, thus facilitating molecular studies of the closely related brackish medaka, such as the cloning, mRNA expression, and *in situ* hybridizations performed in this study. The brackish medaka is therefore an applicable saltwater (including BW and SW) fish model for osmoregulatory studies.

Conclusions {#s5}
===========

The present study revealed that the protein sequences and tissue distributions of FXYD proteins were very similar in the closely related brackish medaka and Japanese medaka species. Upon salinity challenge, however, the expression profiles of most branchial *fxyd* genes differed between the two species. Among the branchial *fxyd* genes, *fxyd11* was highly and specifically expressed in the gills of both medaka species. The expression pattern of branchial *Olfxyd11* was similar to that of the *nka* α-subunit in the Japanese medaka, but non-correlated expression patterns were observed for OdFXYD11 and NKA in the brackish medaka at both the mRNA and protein levels. This finding (non-correlated expression patterns) is the first report of teleost FXYD proteins in a chronic (i.e., acclimated) rather than an acute (i.e., time-course) salinity challenge experiment. Although the brackish medaka and Japanese medaka are very closely related, their branchial FXYD proteins exhibit divergent expression patterns. To our knowledge, this report is the first to focus on FXYD expression in the gills of closely related euryhaline teleosts. Given the sophisticated tools available for the Japanese medaka system, the closely related brackish medaka is highly recommended as a saltwater fish model for osmoregulatory studies.
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Representative immunoblots of FXYD11 and RPL7 in the brackish medaka. (A) Immunoblots of various tissues from freshwater-acclimated brackish medaka showed that FXYD11 (arrow) was only expressed in the gill (G) and had a molecular mass of approximately 10 kDa. (B) Pre-immune serum was used as the negative control for FXYD11. (C) The representative immunoblot of PRL7 in the gills. M, marker (kDa); K, kidney; I, intestine; E, eye; L, liver; Go, gonad; Mu, muscle; FG, the gill from freshwater-acclimated individuals; BG, the gill from brackish water-acclimated individuals; SG, the gill from seawater-acclimated individuals.
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Primer sequences and probe construction used for RACE, RT-PCR, and WISH of *fxyd* genes of the brackish medaka (Od) and Japanese medaka (Ol).
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